雜志介紹

Medicinal Chemistry雜志介紹

《Medicinal Chemistry》是一本以English為主的未開放獲取國際優秀期刊，中文名稱藥物化學，本刊主要出版、報道醫學-CHEMISTRY, MEDICINAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.9，最新CiteScore 指數為4.3。

本刊近期中國學者發表的論文主要有：

• Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.

  Author: Huang Q^1,2, Liu Q³, Ouyang D¹.

• N-(Sulfamoylbenzoyl)-L-proline Derivatives as Potential Non-β-lactam ESBL Inhibitors: Structure-Based Lead Identification, Medicinal Chemistry and Synergistic Antibacterial Activities.

  Author: Liu X¹, Dong S¹, Ma Y¹, Xu H², Zhao H¹, Gao Q¹.

• Synthesis, Molecular Modeling and Biological Evaluation of 5-arylidene-N,N-diethylthiobarbiturates as Potential α-glucosidase Inhibitors.

  Author: Khan M¹, Khan S¹, Ul Mulk A¹, Ur Rahman A¹, Wadood A², Shams S², Ashraf M³, Rahman J³, Khan I⁴, Hameed A⁵, Hussain Z¹, Khan A¹, Zaman K¹, Khan KM^5,6, Perveen S⁷.

• Synthesis and biological evaluation of 5-benzyl-3-pyridyl-1H-1,2,4-triazole derivatives as xanthine oxidase inhibitors.

  Author: Li SY¹, Zhang TJ¹, Wu QX¹, Mohamed OK¹, Zhang Y¹, Meng FH¹.

英文介紹

Medicinal Chemistry雜志英文介紹

Aims & Scope

Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.